Aditi Dutt

Array ( [id] => 6087779 [patent_doc_number] => 20110217264 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-08 [patent_title] => 'METHODS AND COMPOSITIONS FOR DELIVERY OF EXOGENOUS FACTORS TO NERVIOUS SYSTEM SITES' [patent_app_type] => utility [patent_app_number] => 13/108552 [patent_app_country] => US [patent_app_date] => 2011-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 20148 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0217/20110217264.pdf [firstpage_image] =>[orig_patent_app_number] => 13108552 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8829944 [patent_doc_number] => 20130130989 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-23 [patent_title] => 'EIF4E BINDING PEPTIDES' [patent_app_type] => utility [patent_app_number] => 13/695011 [patent_app_country] => US [patent_app_date] => 2011-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 15020 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13695011 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8638195 [patent_doc_number] => 20130029998 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-31 [patent_title] => 'Method of Detecting and Profiling Progression of the Risk of Neurodegenerative Diseases' [patent_app_type] => utility [patent_app_number] => 13/640545 [patent_app_country] => US [patent_app_date] => 2011-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4344 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13640545 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6187578 [patent_doc_number] => 20110171128 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-14 [patent_title] => 'APROTININ POLYPEPTIDES FOR TRANSPORTING A COMPOUND ACROSS THE BLOOD-BRAIN BARRIER' [patent_app_type] => utility [patent_app_number] => 13/042017 [patent_app_country] => US [patent_app_date] => 2011-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 19525 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20110171128.pdf [firstpage_image] =>[orig_patent_app_number] => 13042017 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9827942 [patent_doc_number] => 08937169 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-01-20 [patent_title] => 'Human G-protein chemokine receptor HSATU68' [patent_app_type] => utility [patent_app_number] => 13/018300 [patent_app_country] => US [patent_app_date] => 2011-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 160561 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13018300 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5959524 [patent_doc_number] => 20110183911 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-28 [patent_title] => 'METHOD FOR IMPROVING NEUROTRANSMISSION FAILURE USING A NOVEL AGENT' [patent_app_type] => utility [patent_app_number] => 13/012545 [patent_app_country] => US [patent_app_date] => 2011-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5744 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20110183911.pdf [firstpage_image] =>[orig_patent_app_number] => 13012545 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8950086 [patent_doc_number] => 20130195866 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-01 [patent_title] => 'METHODS TO INHIBIT NEURODEGENERATION' [patent_app_type] => utility [patent_app_number] => 13/574006 [patent_app_country] => US [patent_app_date] => 2011-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 30833 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13574006 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6215542 [patent_doc_number] => 20110137329 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-09 [patent_title] => 'NERVE REGENERATION EMPLOYING KERATIN BIOMATERIALS' [patent_app_type] => utility [patent_app_number] => 13/008136 [patent_app_country] => US [patent_app_date] => 2011-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 12481 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20110137329.pdf [firstpage_image] =>[orig_patent_app_number] => 13008136 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8732666 [patent_doc_number] => 20130078235 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-28 [patent_title] => 'NEUREGULIN BASED COMPOSITIONS AND USES THEREOF FOR PREVENTING, TREATING OR DELAYING THE MYOCARDIAL ISCHEMIA-REPERFUSION INJURY' [patent_app_type] => utility [patent_app_number] => 13/575932 [patent_app_country] => US [patent_app_date] => 2011-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4562 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13575932 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8585669 [patent_doc_number] => 20130004490 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-03 [patent_title] => 'DELIVERY OF TRANSTHYRETIN ACROSS THE BLOOD-BRAIN BARRIER AS A TREATMENT FOR ALZHEIMER\'S DISEASE' [patent_app_type] => utility [patent_app_number] => 13/515050 [patent_app_country] => US [patent_app_date] => 2010-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8004 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13515050 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7484455 [patent_doc_number] => 20110250198 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-13 [patent_title] => 'ActRIIB FUSION POLYPEPTIDES AND USES THEREFOR' [patent_app_type] => utility [patent_app_number] => 12/965219 [patent_app_country] => US [patent_app_date] => 2010-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14185 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0250/20110250198.pdf [firstpage_image] =>[orig_patent_app_number] => 12965219 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10123551 [patent_doc_number] => 09157906 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-10-13 [patent_title] => 'Phosphodiesterase activity and regulation of phosphodiesterase 1B-mediated signaling in brain' [patent_app_type] => utility [patent_app_number] => 12/951775 [patent_app_country] => US [patent_app_date] => 2010-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 33328 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12951775 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5985510 [patent_doc_number] => 20110097726 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-28 [patent_title] => 'REGENERATION AND NEOGENESIS OF RETINAL PHOTORECEPTOR CELL USING OTX2 GENE' [patent_app_type] => utility [patent_app_number] => 12/950123 [patent_app_country] => US [patent_app_date] => 2010-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 15888 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0097/20110097726.pdf [firstpage_image] =>[orig_patent_app_number] => 12950123 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7499449 [patent_doc_number] => 20110262442 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'COMPOSITIONS FOR TREATING CNS DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/941515 [patent_app_country] => US [patent_app_date] => 2010-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 35998 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0262/20110262442.pdf [firstpage_image] =>[orig_patent_app_number] => 12941515 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6149817 [patent_doc_number] => 20110021412 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'Human Receptor Proteins; Related Reagents and Methods' [patent_app_type] => utility [patent_app_number] => 12/902001 [patent_app_country] => US [patent_app_date] => 2010-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22446 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20110021412.pdf [firstpage_image] =>[orig_patent_app_number] => 12902001 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9710308 [patent_doc_number] => 08834874 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-16 [patent_title] => 'Methods and compositions for increasing iduronate 2-sulfatase activity in the CNS' [patent_app_type] => utility [patent_app_number] => 12/901481 [patent_app_country] => US [patent_app_date] => 2010-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 24914 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12901481 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5945107 [patent_doc_number] => 20110105727 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'Method for the humanization of antibodies and humanized antibodies thereby obtained' [patent_app_type] => utility [patent_app_number] => 12/833778 [patent_app_country] => US [patent_app_date] => 2010-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 15412 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20110105727.pdf [firstpage_image] =>[orig_patent_app_number] => 12833778 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6201883 [patent_doc_number] => 20110064669 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-17 [patent_title] => 'USE OF GALANIN IN A METHOD OF TREATING NEURODEGENERATIVE DISEASES OR CONDITIONS' [patent_app_type] => utility [patent_app_number] => 12/829812 [patent_app_country] => US [patent_app_date] => 2010-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 13474 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20110064669.pdf [firstpage_image] =>[orig_patent_app_number] => 12829812 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5969074 [patent_doc_number] => 20110150893 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'ANTI-TRKB MONOCLONAL ANTIBODIES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/827321 [patent_app_country] => US [patent_app_date] => 2010-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 16698 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0150/20110150893.pdf [firstpage_image] =>[orig_patent_app_number] => 12827321 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6495189 [patent_doc_number] => 20100286053 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'PLASMINOGEN ACTIVATOR INHIBITOR AMELIORATION OF NEWBORN HYPOXIC ISCHEMIC BRAIN INJURY' [patent_app_type] => utility [patent_app_number] => 12/775184 [patent_app_country] => US [patent_app_date] => 2010-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 10313 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20100286053.pdf [firstpage_image] =>[orig_patent_app_number] => 12775184 [rel_patent_id] =>[rel_patent_doc_number] =>)